TrialDiabetologia2021

The effect of 6-day subcutaneous glucose-dependent insulinotropic polypeptide infusion on time in glycaemic range in patients with type 1 diabetes: a randomised, double-blind, placebo-controlled crossover trial.

Sebastian M N Heimbürger et al.PubMed ↗Publisher ↗

No numbers read from the abstract.